CINECA IRIS Institutional Research Information System

DE BORTOLI, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.675
EU - Europa 3.544
AS - Asia 2.205
AF - Africa 149
SA - Sud America 54
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 6
Totale 15.653
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.483
IT - Italia 1.567
CN - Cina 1.172
SG - Singapore 537
SE - Svezia 536
BG - Bulgaria 387
DE - Germania 232
GB - Regno Unito 232
VN - Vietnam 198
CA - Canada 185
TR - Turchia 132
FI - Finlandia 107
AT - Austria 100
CI - Costa d'Avorio 90
UA - Ucraina 82
RU - Federazione Russa 61
HK - Hong Kong 50
IN - India 49
CH - Svizzera 45
FR - Francia 35
NL - Olanda 31
PL - Polonia 31
BE - Belgio 28
BR - Brasile 23
NG - Nigeria 23
SN - Senegal 23
AU - Australia 17
ES - Italia 17
PT - Portogallo 14
IR - Iran 12
KR - Corea 12
NO - Norvegia 12
JP - Giappone 10
EG - Egitto 9
CL - Cile 8
AR - Argentina 7
CO - Colombia 7
MX - Messico 7
EU - Europa 6
EC - Ecuador 5
LT - Lituania 5
SK - Slovacchia (Repubblica Slovacca) 5
AE - Emirati Arabi Uniti 4
CZ - Repubblica Ceca 4
ID - Indonesia 4
IL - Israele 4
PE - Perù 4
RS - Serbia 4
GR - Grecia 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PH - Filippine 3
PK - Pakistan 3
TH - Thailandia 3
TW - Taiwan 3
AZ - Azerbaigian 2
BJ - Benin 2
DK - Danimarca 2
AL - Albania 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
DZ - Algeria 1
ET - Etiopia 1
IE - Irlanda 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LU - Lussemburgo 1
RO - Romania 1
Totale 15.653
Salva come PNG Salva come JPEG
Città #
Fairfield 1.097
Woodbridge 1.034
Santa Clara 837
Houston 785
Ann Arbor 759
Chandler 616
Ashburn 554
Seattle 492
Shanghai 457
Serra 454
Cambridge 396
Sofia 387
Wilmington 383
Milan 367
Singapore 295
New York 261
Boardman 223
Beijing 205
Princeton 184
Ottawa 167
Lawrence 153
Medford 145
London 111
Jacksonville 109
Nanjing 98
Dong Ket 94
Abidjan 90
Vienna 88
Des Moines 86
Dearborn 85
Florence 78
Istanbul 66
Izmir 60
Lucca 57
Pisa 56
San Diego 49
Redwood City 47
Rome 45
Bern 43
Hong Kong 43
Nanchang 41
Ogden 30
Falls Church 29
Brussels 27
Washington 27
Hyderabad 26
Shenyang 26
Changsha 25
Fuzhou 24
Dakar 23
Kunming 23
Lagos 23
Los Angeles 23
Bremen 22
Phoenix 22
Lancaster 21
Hebei 19
Jüchen 18
Guangzhou 16
Dallas 15
Council Bluffs 14
Norwalk 13
Alessandria 12
Boulder 12
Frankfurt am Main 12
Hefei 12
Helsinki 12
Chicago 11
Redmond 11
Southend 11
Toronto 11
Lisbon 10
Nowy Sacz 10
Quanzhou 10
Amsterdam 9
Auburn Hills 9
Empoli 9
Groningen 9
Kent 9
Bergen 8
Livorno 8
Shenzhen 8
Tianjin 8
Castelnovo di Sotto 7
Hangzhou 7
Warsaw 7
Xiamen 7
Cairo 6
Melbourne 6
Nuremberg 6
Pescia 6
Pune 6
São Paulo 6
Atlanta 5
Buenos Aires 5
Genoa 5
Indiana 5
Jiaxing 5
Jinan 5
Munich 5
Totale 12.373
Salva come PNG Salva come JPEG
Nome #
Evaluation of Pancreatic Exocrine Function in Patients With Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas 334
Management of Chronic constipation in general practice 194
Symptom analysis improves GERD diagnosis and may be helpful to define a successful surgical approach 175
Randomised clinical trial: twice daily esomeprazole 40 mg vs. pantoprazole 40 mg in Barrett’s oesophagus for 1 year 170
Neuroendocrine Dysregulation in Irritable Bowel Syndrome Patients: A Pilot Study 170
Lactobacillus Casei DG® in Patients with Irritable Bowel Syndrome: Not Only a Change of the Gut Microbiota. A Pilot Study 166
Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics 165
Esophageal chemical clearance and baseline impedance values in patients with chronic autoimmune atrophic gastritis and gastro-esophageal reflux disease 164
Gastroesophageal reflux symptoms among Italian university students: Epidemiology and dietary correlates using automatically recorded transactions 160
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome 149
Not all anti-reflux treatment failures are due to persistence of abnormal esophageal acid exposure 148
Intestinal pseudo-obstruction in inactive systemic lupus erythematosus: An unusual finding 144
Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome 144
Thrombocytopenic purpura: an unusual complication of eradication therapy for Helicobacter pylori 143
Management of chronic constipation in general practice. 142
Radionuclide evaluation of the lower gastrointestinal tract 141
Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? 138
Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: Update of the Porto consensus and recommendations from an international consensus group 134
Suspected laryngopharyngeal reflux evaluated with multichannel impedance and Ph-monitoring. How many are gerd patients? 131
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders 131
Could double-dose PPI therapy modify tissutal homeostasis in patients with barrett esophagus? 130
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients 128
Subthreshold psychiatric psychopathology in Functional gastrointestinal disorders: Can it be the bridge between gastroenterology and psychiatry? 128
Association between baseline impedance values and response proton pump inhibitors in patients with heartburn 128
Voluntary and controlled weight loss can reduce symptoms and proton pump inhibitor use and dosage in patients with gastroesophageal reflux disease: A comparative study 127
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease 125
The pharmacokinetics of ilaprazole for gastro-esophageal reflux treatment 125
Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: Common overlapping gastrointestinal disorders 124
Manually calculated oesophageal bolus clearance time increases in parallel with reflux severity at impedance-pH monitoring 123
“PancPro” as a tool for selecting families eligible for pancreatic cancer screening: An Italian study of incident cases 121
Barrett's esophagus in 2016: From pathophysiology to treatment 121
How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? 121
Assessment of the anti-reflux properties and therapeutic efficacy of Faringel in patients with mild to moderate GERD. 120
Pre-operative clinical and instrumental factors as antireflux surgery outcome predictors 117
Pros and Cons of the SeHCAT Test in Bile Acid Diarrhea: A More Appropriate Use of an Old Nuclear Medicine Technique 117
Irritable bowel syndrome and chronic constipation: Fact and fiction 116
Lower pH values of weakly acidic refluxes as determinants of heartburn perception in gastroesophageal reflux disease patients with normal esophageal acid exposure 116
Esophageal testing: What we have so far 115
Patients with lactose intolerance absorb liquid levothyroxine better than tablet levothyroxine 115
Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn’s disease: pharmacological and clinical implications 115
Clinical and pathophysiological outcomes of the robotic-assisted Heller–Dor myotomy for achalasia: a single-center experience 113
Assessment of bowel wall inflammation in Crohn's disease by a new quantitative ultrasound analysis as compared to vascularization in healthy volunteers bowel wall. 112
Impairment of chemical clearance and mucosal integrity distinguishes hypersensitive esophagus from functional heartburn 112
Esophageal motility abnormalities in gastroesophageal reflux disease 112
Serum pepsinogen I and gastrin-17 levels are predictable of atrophic gastritis in patients with autoimmune thyroiditis and anti-gastric parietal cell autoantibodies. 111
The natural history of gastro-esophageal reflux disease: A comprehensive review 111
Advancements in the use of manometry and impedance testing for esophageal functional disorders 111
Nuclear translocation of GSTO is a progression marker in Barrett’s esophagus. 109
Vonoprazan fumarate for the management of acid-related diseases 109
Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn. 109
Alginate controls heartburn in patients with erosive and nonerosive reflux disease 107
Evaluation of latent links between irritable bowel syndrome and sleep quality 107
Bioelectrical impedance vector analysis in patients with irritable bowel syndrome on a low FODMAP diet: a pilot study 107
The added diagnostic value of postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance in refractory reflux disease studied with on-therapy impedance-pH monitoring 106
Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab 106
Gastrointestinal involvement in systemic sclerosis 105
Efficacy of Nissen fundoplication versus medical therapy in the regression of low-grade dysplasia in patients with Barrett esophagus: a prospective study 104
GSTO: new marker of progression from barrett’s esophagus to adenocarcinoma. 104
Achalasia with dense eosinophilic infiltrate responds to steroid therapy 104
Eosinophilic esophagitis: Update in diagnosis and management. Position paper by the Italian Society of Gastroenterology and Gastrointestinal Endoscopy (SIGE) 104
Nuclear translocation of glutathione transferase omega is a progression marker in Barrett's esophagus 103
Eating habits trajectories of students using university canteens 103
Optimal treatment of laryngopharyngeal reflux disease 103
N-terminal pro-brain natriuretic peptide and tumor necrosis factor-alpha both are increased in patients with Hepatitis C. 102
Lactoferrin and probiotic can improve Helicobacter pylori eradication rate of triple standard therapy. 101
Are PPI responder patients always confirmed as GERD patients? A MII-PH study. 101
Presbifagia Esofagea 101
Vonoprazan for treatment of gastroesophageal reflux: pharmacodynamic and pharmacokinetic considerations 100
Vigor of peristalsis during multiple rapid swallows is inversely correlated with acid exposure time in patients with NERD 99
Analyses of the Post-reflux Swallow-induced Peristaltic Wave Index and Nocturnal Baseline Impedance Parameters Increase the Diagnostic Yield of Impedance-pH Monitoring of Patients With Reflux Disease 97
Optimal management of constipation associated with irritable bowel syndrome 96
Unspecified intestinal malabsorption in patients treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers: a retrospective analysis in primary care settings 96
A review of pharmacotherapy for treating gastroesophageal reflux disease (GERD) 94
Vegetal and Animal Food Proteins Have a Different Impact in the First Postprandial Hour of Impedance-pH Analysis in Patients with Heartburn 94
Updates in the field of non-esophageal gastroesophageal reflux disorder 94
Are IBS patients alexithymic? 93
PP-6 BOLUS CLEARANCE TIME IS ASSOCIATED WITH REFLUX SEVERITY AND IT IS INVERSELY CORRELATED TO BASELINE IMPEDANCE VALUES IN ADOLESCENTS WITH GASTROESOPHAGEAL REFLUX DISEASE 93
Corticosteroid Treatment at Diagnosis: An Analysis of Relapses, Disease Extension, and Colectomy Rate in Ulcerative Colitis 93
Relationship of TT virus and Helicobacter pilori infections in gastric tissues of patients with gastritis 92
Interstitial lung disease in systemic sclerosis patients may benefit more from anti-reflux therapies than from immunosuppressants 92
Brachytherapy for the palliation of dysphagia owing to esophageal cancer: A systematic review and meta-analysis of prospective studies 92
Critical appraisal of Rome IV criteria: hypersensitive esophagus does belong to gastroesophageal reflux disease spectrum 92
Esophagogastric junction morphology is associated with a positive impedance-pH monitoring in patients with GERD 91
Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often than GERD 91
Current and future perspectives in the management of gastroesophageal reflux disease 91
Patients Who Respond to PPI Therapy are Always Considered GERD Patients? a MII-pH Study. 90
Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn’s disease: pharmacological and clinical implications 90
High Resolution and High Definition Anorectal Manometry 89
Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough 88
Jackhammer esophagus with and without esophagogastric junction outflow obstruction demonstrates altered neural control resembling type 3 achalasia 88
Perceptual and multiparametric analysis of the voice in GERD patients 87
Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn 87
Underuse of brachytherapy for the treatment of dysphagia owing to esophageal cancer. An Italian survey 87
Low FODMAP diet: Evidence, doubts, and hopes 86
The placebo effect is a relevant factor in evaluating effectiveness of therapies in functional gastrointestinal disorders 85
Practice guidelines on the use of esophageal manometry - A GISMAD-SIGE-AIGO medical position statement 85
The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal 85
Postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance can link PPI-responsive heartburn to reflux better than acid exposure time 83
High-resolution manometry is superior to endoscopy and radiology in assessing and grading sliding hiatal hernia: A comparison with surgical in vivo evaluation 83
Bile reflux in patients with nerd is associated with more severe heartburn and lower values of mean nocturnal baseline impedance and chemical clearance 83
Totale 11.538
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.431
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.431
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.314 0 0 0 0 0 0 299 247 310 166 216 76
2020/20211.385 104 83 89 145 109 59 91 109 142 107 102 245
2021/20221.652 17 76 37 68 322 258 59 80 104 64 92 475
2022/20232.078 265 305 176 153 200 311 19 149 325 13 134 28
2023/20241.849 183 183 235 168 226 310 91 57 45 50 81 220
2024/20252.463 85 237 187 388 564 721 281 0 0 0 0 0
Totale 16.217